(Q38166180)

30 August 2017

Hepatitis C in 2013: HCV causes systemic disorders that can be cured (English)

1 reference

30 August 2017

Francesco Negro

1

1 reference

PubMed ID

24275792

30 August 2017

language of work or name

English

0 references

publication date

26 November 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

30 August 2017

1 reference

30 August 2017

11

1 reference

30 August 2017

2

1 reference

30 August 2017

77-78

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.222

30 August 2017

0 references

cites work

Global control of hepatitis C: where challenge meets opportunity

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Manifestations of chronic hepatitis C virus infection beyond the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Hepatitis C virus infects the endothelial cells of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Associations of chronic hepatitis C with metabolic and cardiac outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.222

10.1038/NRGASTRO.2013.222

31 March 2020

Identifiers

DOI

1 reference

PubMed ID

24275792

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24275792